PP_1170x120_10-25-21

Diplomat Pharmacy

Diplomat promotes Urick to senior VP

Diplomat promotes Urick to senior VP

FLINT, Mich. — Paul Urick has been promoted to senior vice president of industry relations for pharmaceutical account management and payer strategies at Diplomat Pharmacy Inc. In his expanded role, Urick will now drive efforts in payer strategies through the development of specialty initiatives to reduce costs through patient-centered care, while also continuing to lead

Diplomat’s new online look

Diplomat’s new online look

Diplomat Pharmacy has gone live with what the company describes as a “re-envisioned” website. The nation’s largest independent specialty pharmacy said its revamped website is “user-centric, story-driven, knowledge-based and mobile-friendly.” Key features include a sleek, intuitive layout; fresh, relevant content such as Diplomat’s “Areas of Excellence”; guided user experiences for patients, prescribers and caregivers; and

Diplomat’s Kadlec to chair AFPE

Diplomat’s Kadlec to chair AFPE

FLINT, Mich. — Gary Kadlec, president of specialty pharmacy Diplomat Pharmacy Inc., has been elected as board chairman for the American Foundation for Pharmaceutical Education (AFPE). An independent foundation, the AFPE supports U.S. pharmaceutical education, including graduate education, training and research in such disciplines as clinical pharmaceutical science, medicinal/pharmaceutical chemistry, pharmacology/toxicology, pharmaceutics, pharmacoeconomics, pharmacognosy, pharmacokinetics/metabolism,

Diplomat fully reaccredited by URAC for specialty Rx

FLINT, Mich. — Diplomat Pharmacy Inc. has been awarded full Specialty Pharmacy reaccreditation by URAC, a Washington, D.C.-based health care accrediting organization that establishes quality standards for the health care industry. Diplomat has been fully accredited for specialty pharmacy since 2012. URAC is an independent, nonprofit health care accrediting organization dedicated to promoting health care

Diplomat divesting compounding unit

MADISON, Wis. — Restore Health announced this month it has entered into an agreement to acquire the compounding pharmacy assets of Diplomat Pharmacy Inc. Financial terms of the agreement weren’t disclosed. Restore Health said the deal bolsters its compounding pharmacy and personalized medicine business and enables Diplomat to sharpen its focus on its core specialty

Diplomat sells compounding pharmacy operation

Diplomat sells compounding pharmacy operation

MADISON, Wis. — Personalized medicine solution provider Restore Health plans to acquire the compounding pharmacy assets of Diplomat Pharmacy Inc. Financial terms of the agreement weren’t disclosed. Restore Health said Thursday that the deal bolsters its compounding pharmacy and personalized medicine business and enables Diplomat to sharpen its focus on its core specialty pharmacy operations.

Diplomat Pharmacy: A multifaceted company

Diplomat Pharmacy: A multifaceted company

Describing itself as the nation’s largest independent specialty pharmacy, Diplomat Pharmacy Inc. serves patients and physicians in all 50 states and offers medication management programs for complex chronic diseases, including oncology, immunology, hepatitis, multiple sclerosis, HIV, specialized infusion therapy and many other serious or long-term conditions. The specialty pharmacy provider has made the most of

Diplomat steps to the fore in specialty Rx

Diplomat steps to the fore in specialty Rx

FLINT, Mich. — Diplomat Pharmacy Inc. is a growing company in a quickly growing industry. The specialty pharmacy provider has made the most of its independence, says chairman and chief executive officer Phil Hagerman, and continues to do so after last year’s initial public offering. Even though Diplomat has become publicly traded, “we absolutely still

Diplomat buys specialty pharmacy

FLINT, Mich. — Diplomat Pharmacy Inc. has acquired Burman’s Specialty Pharmacy in an $82.8 million deal. Burman’s, based in Pennsylvania, is a provider of individualized patient care with a primary focus on hepatitis C. “Burman’s shares our strong commitment to patient care,” said Diplomat chairman and chief executive officer Phil Hagerman. “We acquired Burman’s to

Diplomat acquires Burman’s Specialty Pharmacy

Diplomat acquires Burman’s Specialty Pharmacy

FLINT, Mich. — Diplomat Pharmacy Inc. has purchased Burman’s Specialty Pharmacy in a deal valued at more than $82 million. Diplomat said Friday that Burman’s, located in the greater Philadelphia area, is a provider of individualized patient care with a primary focus on hepatitis C. For the 12 months ended May 31, Burman’s generated about

Diplomat launches follow-on stock offering

Diplomat launches follow-on stock offering

FLINT, Mich. — Diplomat Pharmacy Inc. has begun a follow-on public offering of 7.4 million shares of its common stock. The independent specialty pharmacy said late Monday that it’s selling 4.4 million shares of common stock, and certain shareholders are selling 3 million shares of common stock. In addition, the company and selling shareholders aim

Diplomat files for public stock offering

Diplomat files for public stock offering

FLINT, Mich. — Diplomat Pharmacy Inc. has filed a registration statement with the Securities and Exchange Commission for a follow-on public offering of its common stock. The independent specialty pharmacy, the nation’s largest, said late Friday that the offering could raise about $200 million, depending on market conditions. Last October, Diplomat completed an initial public

Diplomat bulks up in infusion services

FLINT, Mich. — Diplomat Pharmacy, which posted strong financial results for fiscal 2014, is acquiring BioRx LLC, a specialized pharmacy and infusion services company. Based in Cincinnati, BioRx provides treatments for patients with ultra-orphan and rare, chronic diseases. Terms of the agreement call for Diplomat to buy BioRx for $210 million in cash and $105